Opiant Pharmaceuticals, Inc.

NASDAQ (USD): Opiant Pharmaceuticals, Inc. (OPNT)

Last Price

16.00

Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.00

Trading Volume

0

Overview

Market Cap

108 Million

Shares Outstanding

5 Million

Avg Volume

72,355

Avg Price (50 Days)

20.50

Avg Price (200 Days)

14.79

PE Ratio

-3.16

EPS

-6.53

Earnings Announcement

03-Aug-2022

Previous Close

20.65

Open

20.88

Day's Range

20.56 - 20.94

Year Range

7.34 - 27.36

Trading Volume

562,778

Price Change Highlight

1 Day Change

0.00%

5 Day Change

0.00%

1 Month Change

-0.58%

3 Month Change

1.82%

6 Month Change

92.09%

Ytd Change

2.03%

1 Year Change

-3.59%

3 Year Change

115.55%

5 Year Change

8.68%

10 Year Change

41200.00%

Max Change

-63.55%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment